Discover 662 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 662
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Cudahy WI, Winfield IL, Palos Hills IL, Munster IN,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Cudahy WI, Milwaukee WI, Chicago IL, Winfield IL,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase 3, Recruiting
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Glendale WI, Tomball TX, Lake Charles LA, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07620392
Phase 2, Recruiting
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
for
Higher-risk Myelodysplastic Syndrome
Location: Milwaukee WI, Waukesha WI, Chicago IL, Rochester MN,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06641414
Phase 3, Recruiting
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
for
Keratitis, Corneal Ulcer
Location: Oshkosh WI, Milwaukee WI, Indianapolis IN,
Sponsor: Peschke GmbH
Sex: All
Age: 18+
Code: NCT05255107
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Milwaukee WI, Gurnee IL, Skokie IL, Schaumburg IL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase 3, Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
for
Coronary Artery Disease
Location: Milwaukee WI, Royal Oak MI, Indianapolis IN,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT07045194
Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Milwaukee WI, Appleton WI, Zion IL, Chicago Ridge IL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Milwaukee WI, Hoffman Estates IL, Elk Grove Village IL,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement